Fast Five Quiz: Type 2 Diabetes and Cerebrovascular Disease

Romesh Khardori, MD, PhD, FACP


April 27, 2022

Most patients with diabetes and hypertension should be treated to a blood pressure of < 140/90 mm Hg; individuals at high risk for stroke may have lower targets, such as < 130/80 mm Hg. Studies have reported that a lower blood pressure for high-risk individuals reduced the risk for stroke, retinopathy, and albuminuria.

Long-term intensive glycemic control has not been shown to improve cerebrovascular outcomes in patients with type 2 diabetes. Systolic blood pressure may be a stronger risk factor for cerebrovascular disease in patients with type 2 diabetes than glycemic control.

According to the American Diabetes Association, statin therapy is recommended for all patients with type 2 diabetes between the ages 40 and 75 years. Higher-intensity statins and a longer duration of statin therapy may reduce the risk for atherosclerotic events, including stroke.

Thirty minutes or more of moderate-intensity daily physical activity is recommended for the primary prevention of stroke in patients with diabetes.

Learn more about type 2 diabetes.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.